China's Sinopharm to test potential COVID-19 vaccine in Brazil

Clay Curtis
July 30, 2020

The source added that Russian health workers treating COVID-19 patients will be offered the chance of volunteering to be vaccinated soon after the vaccine receives the regulatory approval.

The press service of the Russian Direct Investment Fund (RDIF), which is coordinating and funding Russia's vaccine development efforts, declined to comment, but its head, Kirill Dmitriev, has denied that Russia's vaccine push is compromising safety.

The speed at which Russian Federation is moving to roll out the vaccine has prompted some Western media to question whether Moscow is putting national prestige before solid science and safety.

In other countries Gamaleya is scheduled to begin Phase 3 trials next week in Russia, Saudi Arabia and the United Arab Emirates.

At a meeting chaired by Russian President Vladimir Putin, Deputy Prime Minister Tatyana Golikova singled out two vaccines under development by a research institute in Moscow and a lab in Siberia.

Dozens of vaccine trials are underway around the world and a small number are in large-scale efficacy trials, but most developers have cautioned that much work remains before their vaccines can be approved. So, apprehensions remain over the safety and efficacy of the vaccine.

"There are also wide concerns the human testing of the vaccine is incomplete", the report highlighted.

Paparazzi captured a fight Kim Kardashian and Kanye West after the scandal
While Kim has been by Kanye's side throughout his battle with bipolar disorder , she fears this time he may have hit rock bottom. They married in 2014, and in addition to North , share Saint , 4, Chicago , 2, and Psalm , 14 months.

Based on the latest update of the World Health Organization, the Oxford-Astrazeneca vaccine is now leading among candidate vaccines as it is in the Phase III or large-scale clinical trials already, alongside 3 vaccines from China.

Russia's defence ministry says that Russian soldiers served as volunteers in human trials.

Despite the relatively quick progress of vaccine developers, some groups have expressed worry that poor countries won't have access to the vaccine, which are being developed in richer countries like the United States.

Russian Federation has over 800,000 confirmed cases of COVID-19, the fourth-most in the world.

"Russia marshalled its leadership position in vaccine development and its proven Ebola and MERS vaccine platform to bring the first safe and efficient solution to the world's biggest problem", Dmitriev told CNN previously. In Phase 2, the clinical study is expanded and the vaccine is given to people who have characteristics - such as age and physical health - similar to those for whom the new vaccine is intended, according to the US Centers for Disease Control and Prevention. "We now need to move into larger scale real-world trials, but it is good to see more data and more products moving into this very important phase of vaccine discovery".

The Russian government denied the allegations.

Other reports by

Discuss This Article